Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03538340
Other study ID # HP-00079115
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date January 31, 2023

Study information

Verified date April 2021
Source University of Maryland, Baltimore
Contact Melissa Culligan, RN, MS
Phone 410-328-6366
Email mculligan@som.umaryland.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The ICE Study study will compare standard therapy (thoracic epidural) versus a novel approach (Cryoanalgesia combined with thoracic epidural) in subjects undergoing unilateral thoracotomy.


Description:

The ICE Study is a single institution pilot study designed to compare standard therapy (i.e., thoracic epidural) versus a novel approach (i.e., Cryoanalgesia combined with thoracic epidural) to address the need for better management of acute and long-term pain in the general thoracic surgery patient population. The study's primary objective will be to demonstrate if the new intraoperative pain management approach [i.e., intercostal Cryoanalgesia in conjunction with thoracic epidural] provides superior short-term and long-term analgesia efficacy in patients undergoing unilateral thoracotomy as compared to the current institutional standard of care (i.e., thoracic epidural). Patients will be randomized in a 1:1 design.


Recruitment information / eligibility

Status Recruiting
Enrollment 138
Est. completion date January 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing unilateral thoracotomy for non-cardiac surgery - Age 18-85 years of age; male or female - Acceptable surgical candidate including use of general anesthesia - Willing and able to provide written informed consent - Willing and able to return for scheduled follow-up visits Exclusion Criteria: - Prior major surgery within the last 6-months - Documented psychiatric disease - Documented chronic pain syndrome - Current use of prescription opioids - Documented history of substance abuse - Functional disability or impairment (ECOG score = 0 or 1) - Current pregnancy - Patients currently enrolled in another research study that could directly affect results of either study - Physical or mental condition that would interfere with patient's self-assessment of pain - A medical condition that in the investigator's opinion could adversely impact the patient's participation or safety, conduct of the study or interferes with the pain assessments

Study Design


Intervention

Procedure:
Thoracic Epidural
The control arm will receive standard of care pain management which includes a Thoracic Patient Controlled Epidural
Intercostal Cryoanalgesia
The study arm will receive standard of care pain management which includes a Thoracic Epidural plus Intraoperative Intercostal Cryoanalgesia

Locations

Country Name City State
United States University of Maryland Medical Center Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
University of Maryland, Baltimore AtriCure, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total narcotic use post-thoracotomy. The primary outcome measure of this study is to determine if the addition of Cryoanalgesia to standard of care post thoracotomy pain control, results in decreased pain and/or narcotic use at time points ranging from perioperative to six months post discharge. 6 months
Secondary Visual Analog Scale (VAS) Assessment of post-thoracotomy pain Visual Analog Scale will be used to assess pain levels (0-10 range scale with 0=no pain and 10= worse pain ever 6 months
Secondary Quality of Life (SF-36) changes from baseline to 6-months Assessment of the impact of pain on quality of life (questions using varied assessment scales: rating general health from excellent to poor; yes-no; none to very severe; not at all to extremely; all of the time to none of the time; true-false 6 months
Secondary Allodynia Assessment Allodynia screening and assessments will assess the levels of skin hypersensitivity associated with neuropathic pain following thoracotomy and will be performed at predetermined time points 6 months
Secondary Mankoski Pain Scale Assessment of post-thoracotomy pain Mankoski Pain Scale will be used to assess pain levels (scale ranging from 0 to 10 with 0 = no pain to 10 = worse pain ever 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04585620 - Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery Phase 1/Phase 2
Completed NCT04990700 - Effect of Partial Rib Resection On the Control of Post-thoracotomy Pain N/A
Recruiting NCT05379816 - Persistent Pain Induced by Uniportal Video-assisted Thoracic Surgery N/A
Completed NCT05962736 - The Effect of Mirror Therapy After Thoracotomy N/A
Completed NCT04531553 - Erector Spinae Plane Block for Post-thoracotomy Pain Control N/A
Completed NCT06398834 - Esketamine and Butorphanol for Post-Lobectomy Pain Phase 4
Not yet recruiting NCT05409144 - Impact of Thoracic Epidural Versus Serratus Anterior Plane Block Versus Erector Spinae Plane Block on Incidence of PTPS N/A
Recruiting NCT04415242 - IMPACT OF OPERATIVE POSITIONING ON THE DEVELOPMENT OF SHOULDER PAIN AFTER PULMONARY LOBECTOMY BY VATS N/A
Withdrawn NCT03051932 - Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery N/A
Recruiting NCT05791539 - Comparison Between Retrolaminar Block Combined With Erector Spinae Plane Block, and Erector Spinae Plane Block Alone for Post-thoracotomy Pain N/A
Terminated NCT04258436 - Serratus Anterior Plane Block for Management of Post Thoracotomy Pain N/A
Completed NCT02619513 - Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks Phase 4
Completed NCT04189120 - The Effect of Ultrasound Guided Superficial, Deep Serratus Plane Blocks and Thoracic Epidural in Thoracotomy N/A